Trials / Completed
CompletedNCT02205840
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
A Multicenter, Randomized, Double-masked and Placebo-controlled Study Evaluating the Efficacy and Safety of SI-614 Ophthalmic Solution in Patients With Dry Eye
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Seikagaku Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and effectiveness of SI-614 solution compared with placebo solution in treating patients with dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SI-614 | 1 drop in each eye |
| DRUG | Vehicle | 1 drop in each eye |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-11-01
- First posted
- 2014-07-31
- Last updated
- 2023-07-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02205840. Inclusion in this directory is not an endorsement.